Clinical Case Database / Category: Patient Management

Carcinoid tumours

Publication details

Burhan Khan, Asad Ali Khan, Majid Mushtaq
Foundation Years Journal, volume 4, issue 9, p.16 (123Doc Education, London, December 2010)

Abstract

Carcinoid tumours are slow-growing neuroendocrine neoplasms that often are indolent and may not become clinically apparent unless develops metastases or carcinoid syndrome. As they originate from neuroendocrine cells, they have secretory properties and may frequently present with hypersecretory syndromes. Carcinoid syndrome usually manifests once liver metastases are present, secreting hormones directly into the systemic circulation. Overall incidence is estimated to be 2–3 cases per 100,000 people annually, but recent evidence suggests the incidence is steadily increasing. Although the disease was thought to be relatively benign, it is now considered to be one of increasing malignancy. They can present in a myriad of ways and at times present a diagnostic challenge. The choice of treatments depends on the symptoms, stage of the disease, degree of uptake of radionuclide and histological features of the tumour.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

ProductPriceSubscription
Foundation Years Clinical Cases Database£29.006 months
Add to cart
Foundation Years Clinical Cases Database£39.0012 months
Add to cart

Authors

Burhan Khan

Specialist Registrar Respiratory & General Medicine
Darent Valley Hospital
Kent DA2 8DA

Asad Ali Khan

Speciality Doctor Gastroenterology
Grantham & District General Hospital
Grantham NG31 8DG

Majid Mushtaq

Consultant Physician & Clinical Director
Darent Valley Hospital
Kent DA2 8DA

References

1. Ramage JK, Davies AHG, Ardill J, et al. (2005) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut, 54(Suppl IV): iv1–iv16.
2. Feldman JM, O'Dorisio TM. (1986) Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med, 81:Suppl 6B: 41–48.
3. Namwongprom S, Wong FC, Tateishi u, et al. (2008) Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors. Ann Nucl Med, 22(4):237–243.
4. Krenning EP, Kwekkeboom DJ, Oei HY, et al. (1994) Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors: an overview of European results. Ann N Y Acad Sci, 733: 416–424.
5. Kulke MH, Mayer RJ. (1999) Carcinoid tumors. N Eng J Med, 340: 858–868.
6. Caplin ME, Buscombe JR, Hilson AJ, et al. (1998) Carcinoid tumour. Lancet, 352: 799–805.
7. Metz DC, Jensen RT. (2003) Endocrine tumours of the gastrointestinal tract. In AK Rustgi, JM Crawford (eds) Gastrointestinal Cancers. Edinburgh: Saunders: 681–720.
8. Bushnell D. (2009) Treatment of metastatic carcinoid tumors with radiolabelled biological molecules. J Natl Compr Canc Netw, 7: 760–764.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.